|
Male (n, %)
|
330 (40.34%)
|
210 (41.18%)
|
540 (40.66%)
|
0.763
|
|
Age, years (mean, SD)
|
52.80 (14.22)
|
48.34 (14.49)
|
51.08 (14.47)
|
< 0.001
|
|
Weight, kg (mean, SD)
|
65.07 (12.60)
|
69.99 (14.24)
|
66.95 (13.46)
|
< 0.001
|
|
BMI, kg/m2 (mean, SD)
|
23.96 (3.65)
|
25.18 (4.08)
|
24.43 (3.87)
|
< 0.001
|
|
Waist, cm (mean, SD)
|
86.46 (10.19)
|
88.79 (11.07)
|
87.35 (10.59)
|
< 0.001
|
|
Fat, % (mean, SD)
|
28.37 (7.70)
|
29.81 (8.25)
|
28.91 (7.94)
|
0.004
|
|
SBP, mmHg (mean, SD)
|
130.39 (18.17)
|
130.23 (17.41)
|
130.33 (17.88)
|
0.880
|
|
DBP, mmHg (mean, SD)
|
79.02 (10.93)
|
79.20 (11.33)
|
79.09 (11.09)
|
0.776
|
|
Diabetic family history (n, %)
|
351 (44.94%)
|
249 (50.82%)
|
1271 (47.21%)
|
0.041
|
|
Hypertension (n, %)
|
279 (34.15%)
|
160 (31.37%)
|
1327 (33.08%)
|
0.296
|
|
Dislipidemia (n, %)
|
249 (30.48%)
|
168 (33.01%)
|
1326 (31.45%)
|
0.335
|
|
Higher Education (n, %)
|
370 (45.23%)
|
312 (61.18%)
|
1328 (51.36%)
|
< 0.001
|
|
Current smoke (n, %)
|
104 (12.73%)
|
91 (17.88%)
|
1326 (14.71%)
|
0.010
|
|
Current alcohol intake (n, %)
|
115/703 (14.06%)
|
107/402 (21.02%)
|
222 (16.73%)
|
0.001
|
|
Tea consumption (n, %)
|
293 (35.91%)
|
321 (62.94%)
|
1326 (46.30%)
|
< 0.001
|
|
Frequent physical activity (n, %)
|
629 (76.99%)
|
385 (75.49%)
|
1327 (76.41%)
|
0.532
|
|
FPG, mmol/L (median, IQR)
|
6.15 (5.46–7.06)
|
6.04 (5.36–7.14)
|
6.11 (5.42–7.08)
|
0.259
|
|
PG30min, mmol/L (median, IQR)
|
10.67 (9.09–12.38)
|
10.47 (9.05–12.27)
|
10.60 (9.07–12.35)
|
0.188
|
|
PG1h, mmol/L (median, IQR)
|
12.29 (9.79–15.25)
|
12.19 (9.43–14.97)
|
12.25 (9.68–15.14)
|
0.148
|
|
PG2h, mmol/L (median, IQR)
|
10.02 (7.36–14.31)
|
9.53 (7.09–13.47)
|
9.85 (7.28–14.06)
|
0.024
|
|
PG3h, mmol/L (median, IQR)
|
6.69 (4.84–9.62)
|
6.30 (4.55–8.97)
|
6.45 (4.74–9.35)
|
0.016
|
|
FIN, uIU/mL (median, IQR)
|
8.43 (5.75–12.61)
|
10.10 (6.94–16.22)
|
9.08 (6.02–13.81)
|
< 0.001
|
|
IN30min, uIU/mL (median, IQR)
|
44.05 (27.52–69.97)
|
58.09 (34.50–93.70)
|
48.21 (28.82–80.23)
|
< 0.001
|
|
IN1h, uIU/mL (median, IQR)
|
64.58 (40.18–101.45)
|
77.03 (50.30–121.83)
|
69.20 (44.25–107.50)
|
< 0.001
|
|
IN2h, uIU/mL (median, IQR)
|
69.91 (45.83–115.70)
|
81.54 (51.53–128.38)
|
74.75 (48.05–119.05)
|
0.002
|
|
IN3h, uIU/mL (median, IQR)
|
32.22 (17.34–57.65)
|
34.29 (18.23–62.04)
|
32.75 (17.64–58.38)
|
0.237
|
|
HbA1c, % (median, IQR)
|
6.00 (5.60–6.50)
|
5.90 (5.50–6.60)
|
5.90 (5.60–6.50)
|
0.855
|
|
GA, % (median, IQR)
|
14.30 (12.80–16.60)
|
13.85 (12.40–16.70)
|
14.10 (12.70–16.68)
|
0.263
|
|
Newly diagnosed diabetes (n, %)
|
381 (46.58%)
|
213 (41.76%)
|
594 (44.73%)
|
0.037
|
|
Impaired glucose regulation (n, %)
|
237 (28.97%)
|
148 (29.02%)
|
385 (28.99%)
|
0.241
|
|
HOMA-β (mean, SD)
|
84.30 (89.77)
|
104.65 (103.29)
|
92.11 (95.66)
|
< 0.001
|
|
HOMA-IR (median, IQR)
|
2.37 (1.49–3.71)
|
2.80 (1.75–4.61)
|
2.52 (1.60–4.04)
|
< 0.001
|
|
Stumvoll first phase (mean, SD)
|
459.97 (1096.52)
|
717.67 (1060.32)
|
558.85 (1089.60)
|
< 0.001
|
|
Stumvoll second phase (mean, SD)
|
179.32 (248.52)
|
242.04 (246.55)
|
203.33 (249.54)
|
< 0.001
|
